0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Statin Use and Risk of Diabetes

Harold Zeliger, PhD
Arch Intern Med. 2012;172(11):896-897. doi:10.1001/archinternmed.2012.1243.
Text Size: A A A
Published online

Extract

The findings reported by Culver et al1 on the association between the risk of diabetes mellitus (DM) and the use of all types of statins suggest that a common mechanism for this causative effect exists. Although the 5 statins reported on (lovastatin, simvastatin, fluvastatin, atorvastatin, and pravastatin) differ significantly from each other in many ways, all share 1 common trait—all are lipophilic species.2 A strong dose-response relationship between serum concentrations of lipophilic persistent organic pollutants (POPs), including organochlorine pesticides, polychlorinated biphenyls, dioxins, furans, and polybrominated biphenyl ethers, and diabetes has been reported.3 Increased DM prevalence has also been reported for those exposed to other lipophilic chemicals including environmental tobacco smoke.4 Could the lipophilic statins be behaving in a mechanistic manner similar to these other lipophilic exogenous chemicals in acting to increase the risk of DM? Though statins are not as long lived in the body as POPs, an individual taking statins on a regular basis can effectively establish a steady-state level of these lipophilic species in his or her serum that can function in a manner similar to POPs and other lipophilic chemicals. A significant association between regular use of lipophilic pharmaceuticals and metabolic impact has been reported in populations other than the postmenopausal women described by Culver et al.1 A just-published article reports a high prevalence of metabolic syndrome in children treated with lipophilic second-generation antipsychotics.5 These findings suggest that the association between statin use and DM may be due to the lipophilicity of the statins. Notably, the only hydrophilic statin, cerivastatin,2 was not part of the reported study.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

June 11, 2012
Annie L. Culver, BPharm; Ira S. Ockene, MD; Yunsheng Ma, MD, PhD
Arch Intern Med. 2012;172(11):896-897. doi:10.1001/archinternmed.2012.1613.
CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Jobs
JAMAevidence.com

Users' Guides to the Medical Literature
Clinical Scenario

Users' Guides to the Medical Literature
Statin Dosing and LDL Levels

brightcove.createExperiences();